activity
20142025
most citedBayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times

94 citations · 205 across the 7 of their papers we have counts for

collaborators

7 papers

stat.ME2025

A Dependent Feature Allocation Model Based on Random Fields

Bernardo Flores, Yang Ni, Yanxun Xu +1

We introduce a flexible framework for modeling dependent feature allocations. Our approach addresses limitations in traditional nonparametric methods by directly modeling the logit…

stat.ME2019★ 4 cited

A Bayesian Nonparametric Approach for Evaluating the Causal Effect of Treatment in Randomized Trials with Semi-Competing Risks

Yanxun Xu, Daniel Scharfstein, Peter Müller +1

We develop a Bayesian nonparametric (BNP) approach to evaluate the causal effect of treatment in a randomized trial where a nonterminal event may be censored by a terminal event, b…

stat.ME2015★ 25 cited

Bayesian Inference for Latent Biologic Structure with Determinantal Point Processes (DPP)

Yanxun Xu, Peter Mueller, Donatello Telesca

We discuss the use of the determinantal point process (DPP) as a prior for latent structure in biomedical applications, where inference often centers on the interpretation of laten…

stat.AP2014★ 94 cited

Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times

Yanxun Xu, Peter Mueller, Abdus S. Wahed +1

Dynamic treatment regimes in oncology and other disease areas often can be characterized by an alternating sequence of treatments or other actions and transition times between dise…

stat.ME2014★ 3 cited

A Latent Gaussian Process Model with Application to Monitoring Clinical Trials

Yanxun Xu, Yuan Ji

In many clinical trials treatments need to be repeatedly applied as diseases relapse frequently after remission over a long period of time (e.g., 35 weeks). Most research in statis…

stat.AP2014★ 42 cited

Subgroup-Based Adaptive (SUBA) Designs for Multi-Arm Biomarker Trials

Yanxun Xu, Lorenzo Trippa, Peter Müller +1

Targeted therapies based on biomarker profiling are becoming a mainstream direction of cancer research and treatment. Depending on the expression of specific prognostic biomarkers,…

stat.ME2014★ 37 cited

MAD Bayes for Tumor Heterogeneity Feature Allocation with Non-Normal Sampling

Yanxun Xu, Peter Mueller, Yuan Yuan +2

We propose small-variance asymptotic approximations for the inference of tumor heterogeneity (TH) using next-generation sequencing data. Understanding TH is an important and open r…